Registro:

Referencias:

• Stouffer, R.L., Martinez-Chequer, J.C., Molskness, T.A., Xu, F., Hazzard, T.M., Regulation and action of angiogenic factors in the primate ovary (2001) Arch Med Res, 32, pp. 567-575
• Tamanini, C., De Ambrogi, M., Angiogenesis in developing follicle and corpus luteum (2004) Reprod Domest Anim, 39, pp. 206-216
• Zeleznik, A.J., Schuler, H.M., Reichert Jr., L.E., Gonadotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle (1981) Endocrinology, 109, pp. 356-362
• Ferrara, N., Molecular and biological properties of vascular endothelial growth factor (1999) J Mol Med, 77, pp. 527-543
• Zimmermann, R.C., Hartman, T., Kavic, S., Pauli, S.A., Bohlen, P., Sauer, M.V., Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development (2003) J Clin Invest, 112, pp. 659-669
• Wulff, C., Wilson, H., Wiegand, S.J., Rudge, J.S., Fraser, H.M., Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2 (2002) Endocrinology, 143, pp. 2797-2807
• Hazzard, T.M., Xu, F., Stouffer, R.L., Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys (2002) Biol Reprod, 67, pp. 1305-1312
• Abramovich, D., Parborell, F., Tesone, M., Effect of a vascular endothelial growth factor (VEGF) inhibitory treatment on the folliculogenesis and ovarian apoptosis in gonadotropin-treated prepubertal rats (2006) Biol Reprod, 75, pp. 434-441
• Parborell, F., Abramovich, D., Tesone, M., Intrabursal administration of the antiangiopoietin 1 antibody produces a delay in rat follicular development associated with an increase in ovarian apoptosis mediated by changes in the expression of BCL2 related genes (2008) Biol Reprod, 78, pp. 506-513
• Gerber, H.P., Dixit, V., Ferrara, N., Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells (1998) J Biol Chem, 273, pp. 13313-13316
• Gerber, H.P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B.A., Dixit, V., Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation (1998) J Biol Chem, 273, pp. 30336-30343
• Gora-Kupilas, K., Josko, J., The neuroprotective function of vascular endothelial growth factor (VEGF) (2005) Folia Neuropathol, 43, pp. 31-39
• Rosenstein, J.M., Krum, J.M., New roles for VEGF in nervous tissue-beyond blood vessels (2004) Exp Neurol, 187, pp. 246-253
• Rissanen, T.T., Vajanto, I., Hiltunen, M.O., Rutanen, J., Kettunen, M.I., Niemi, M., Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration (2002) Am J Pathol, 160, pp. 1393-1403
• Greenaway, J., Connor, K., Pedersen, H.G., Coomber, B.L., LaMarre, J., Petrik, J., Vascular endothelial growth factor and its receptor, Flk-1/KDR, are cytoprotective in the extravascular compartment of the ovarian follicle (2004) Endocrinology, 145, pp. 2896-2905
• Andjelkovic, M., Alessi, D.R., Meier, R., Fernandez, A., Lamb, N.J., Frech, M., Role of translocation in the activation and function of protein kinase B (1997) J Biol Chem, 272, pp. 31515-31524
• Datta, S.R., Brunet, A., Greenberg, M.E., Cellular survival: a play in three Akts (1999) Genes & Dev, 13, pp. 2905-2927
• Fujio, Y., Walsh, K., Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner (1999) J Biol Chem, 274, pp. 16349-16354
• Jin, K.L., Mao, X.O., Greenberg, D.A., Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia (2000) Proc Natl Acad Sci U S A, 97, pp. 10242-10247
• Banerjee, S., Mehta, S., Haque, I., Sengupta, K., Dhar, K., Kambhampati, S., VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis (2008) Biochemistry, 47, pp. 3345-3351
• Woodruff, T.K., Lyon, R.J., Hansen, S.E., Rice, G.C., Mather, J.P., Inhibin and activin locally regulate rat ovarian folliculogenesis (1990) Endocrinology, 127, pp. 3196-3205
• Rasband, W.S., Image J.U.S. National Institutes of Health, , http://rsb.info.nih.gov/ij, Bethesda, Maryland, USA. Available at:, Accessed: 2009
• Tilly, J.L., Billig, H., Kowalski, K.I., Hsueh, A.J., Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism (1992) Mol Endocrinol, 6, pp. 1942-1950
• Parborell, F., Irusta, G., Vitale, A.M., Gonzalez, O., Pecci, A., Tesone, M., GnRH antagonist Antide inhibits apoptosis of preovulatory follicle cells in rat ovary (2005) Biol Reprod, 72, pp. 659-666
• Grasselli, F., Basini, G., Bussolati, S., Tamanini, C., Effects of VEGF and bFGF on proliferation and production of steroids and nitric oxide in porcine granulosa cells (2002) Reprod Domest Anim, 37, pp. 362-368
• Boone, D.L., Tsang, B.K., Caspase-3 in the rat ovary: localization and possible role in follicular atresia and luteal regression (1998) Biol Reprod, 58, pp. 1533-1539
• Xu, F., Hazzard, T.M., Evans, A., Charnock-Jones, S., Smith, S., Stouffer, R.L., Intraovarian actions of anti-angiogenic agents disrupt periovulatory events during the menstrual cycle in monkeys (2005) Contraception, 71, pp. 239-248
• Jiang, B.H., Liu, L.Z., PI3K/PTEN signaling in tumorigenesis and angiogenesis (2008) Biochim Biophys Acta, 1784, pp. 150-158
• Wulff, C., Wiegand, S.J., Saunders, P.T., Scobie, G.A., Fraser, H.M., Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap(A40)) (2001) Endocrinology, 142, pp. 3244-3254
• Taylor, P.D., Hillier, S.G., Fraser, H.M., Effects of GnRH antagonist treatment on follicular development and angiogenesis in the primate ovary (2004) J Endocrinol, 183, pp. 1-17
• Hu, L., Hofmann, J., Holash, J., Yancopoulos, G.D., Sood, A.K., Jaffe, R.B., Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model (2005) Clin Cancer Res, 11, pp. 6966-6971
• Le, X.F., Mao, W., Lu, C., Thornton, A., Heymach, J.V., Sood, A.K., Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2 (2008) Cell Cycle, 7, pp. 3747-3758
• Fraser, H.M., Wilson, H., Silvestri, A., Morris, K.D., Wiegand, S.J., The role of vascular endothelial growth factor and estradiol in the regulation of endometrial angiogenesis and cell proliferation in the marmoset (2008) Endocrinology, 149, pp. 4413-4420
• Rini, B.I., Rathmell, W.K., Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma (2007) Clin Cancer Res, 13, pp. 741s-746s
• Riely, G.J., Miller, V.A., Vascular endothelial growth factor trap in non small cell lung cancer (2007) Clin Cancer Res, 13, pp. s4623-s4627
• Nguyen, Q.D., Shah, S.M., Hafiz, G., Quinlan, E., Sung, J., Chu, K., A phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degeneration (2006) Ophthalmology, 113. , 1522e1-e14

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------